prothromplex total süstelahuse pulber ja lahusti
baxalta innovations gmbh - inimese protrombiinkompleks - süstelahuse pulber ja lahusti - 600rÜ 1tk
shingrix
glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vaktsiinid - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. kasutada shingrix peab olema kooskõlas ametlike soovitustega.
nuvaxovid
novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratoorsed süntsüütilised viirusinfektsioonid - vaktsiinid - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
vesicare õhukese polümeerikattega tablett
astellas pharma d.o.o. - solifenatsiin - õhukese polümeerikattega tablett - 5mg 50tk; 5mg 3tk; 5mg 20tk; 5mg 100tk; 5mg 90tk; 5mg 60tk; 5mg 5tk
vesicare õhukese polümeerikattega tablett
astellas pharma d.o.o. - solifenatsiin - õhukese polümeerikattega tablett - 10mg 3tk; 10mg 50tk; 10mg 60tk; 10mg 100tk; 10mg 10tk; 10mg 90tk; 10mg 20tk; 10mg 30tk
vesicare suukaudne suspensioon
astellas pharma d.o.o. - solifenatsiin - suukaudne suspensioon - 1mg 1ml 150ml 1tk
exelon
novartis europharm limited - rivastigmiin - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - kerge kuni mõõdukalt raskekujulise alzheimeri tõve sümptomaatiline ravi. sümptomaatiline ravi kerge kuni mõõdukalt raske dementsuse patsientidel, kellel on idiopaatiline parkinsoni tõbi.
urizia toimeainet modifitseeritult vabastav tablett
astellas pharma d.o.o. - tamsulosiin+solifenatsiin - toimeainet modifitseeritult vabastav tablett - 0,4mg+6mg 30tk; 0,4mg+6mg 28tk; 0,4mg+6mg 100tk; 0,4mg+6mg 90tk; 0,4mg+6mg 56tk; 0,4mg+6mg 10tk; 0,4mg+6mg 20tk; 0,4mg+6mg 14tk; 0,4mg+6mg 60tk; 0,4mg+6mg 200tk
lutetium (177lu) chloride billev (previously illuzyce)
billev pharma aps - lutetium (177lu) chloride - radionukliidi pildistamine - terapeutilised radiofarmatseutilised ühendid - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.